133 related articles for article (PubMed ID: 23294633)
21. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.
Pérez M; Ribe E; Rubio A; Lim F; Morán MA; Ramos PG; Ferrer I; Isla MT; Avila J
Neuroscience; 2005; 130(2):339-47. PubMed ID: 15664690
[TBL] [Abstract][Full Text] [Related]
22. Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology?
Muyllaert D; Kremer A; Jaworski T; Borghgraef P; Devijver H; Croes S; Dewachter I; Van Leuven F
Genes Brain Behav; 2008 Feb; 7 Suppl 1():57-66. PubMed ID: 18184370
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies.
Hart de Ruyter FJ; Morrema THJ; den Haan J; ; Twisk JWR; de Boer JF; Scheltens P; Boon BDC; Thal DR; Rozemuller AJ; Verbraak FD; Bouwman FH; Hoozemans JJM
Acta Neuropathol; 2023 Feb; 145(2):197-218. PubMed ID: 36480077
[TBL] [Abstract][Full Text] [Related]
24. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau.
Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW
J Neurocytol; 2003 Nov; 32(9):1091-105. PubMed ID: 15044841
[TBL] [Abstract][Full Text] [Related]
25. Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease.
Rosi MC; Luccarini I; Grossi C; Fiorentini A; Spillantini MG; Prisco A; Scali C; Gianfriddo M; Caricasole A; Terstappen GC; Casamenti F
J Neurochem; 2010 Mar; 112(6):1539-51. PubMed ID: 20050968
[TBL] [Abstract][Full Text] [Related]
26. Tau-tubulin kinase 1 enhances prefibrillar tau aggregation and motor neuron degeneration in P301L FTDP-17 tau-mutant mice.
Xu J; Sato S; Okuyama S; Swan RJ; Jacobsen MT; Strunk E; Ikezu T
FASEB J; 2010 Aug; 24(8):2904-15. PubMed ID: 20354135
[TBL] [Abstract][Full Text] [Related]
27. Hippocampal neuronal subpopulations are differentially affected in double transgenic mice overexpressing frontotemporal dementia and parkinsonism linked to chromosome 17 tau and glycogen synthase kinase-3beta.
Engel T; Goñi-Oliver P; Gomez-Ramos P; Morán MA; Lucas JJ; Avila J; Hernández F
Neuroscience; 2008 Dec; 157(4):772-80. PubMed ID: 18951953
[TBL] [Abstract][Full Text] [Related]
28. The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy.
Hansen HH; Barkholt P; Fabricius K; Jelsing J; Terwel D; Pyke C; Knudsen LB; Vrang N
Brain Res; 2016 Mar; 1634():158-170. PubMed ID: 26746341
[TBL] [Abstract][Full Text] [Related]
29. Tau overexpression inhibits cell apoptosis with the mechanisms involving multiple viability-related factors.
Wang HH; Li HL; Liu R; Zhang Y; Liao K; Wang Q; Wang JZ; Liu SJ
J Alzheimers Dis; 2010; 21(1):167-79. PubMed ID: 20413892
[TBL] [Abstract][Full Text] [Related]
30. Elevated levels of soluble total and hyperphosphorylated tau result in early behavioral deficits and distinct changes in brain pathology in a new tau transgenic mouse model.
Flunkert S; Hierzer M; Löffler T; Rabl R; Neddens J; Duller S; Schofield EL; Ward MA; Posch M; Jungwirth H; Windisch M; Hutter-Paier B
Neurodegener Dis; 2013; 11(4):194-205. PubMed ID: 22797329
[TBL] [Abstract][Full Text] [Related]
31. Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation.
Xiong Y; Jing XP; Zhou XW; Wang XL; Yang Y; Sun XY; Qiu M; Cao FY; Lu YM; Liu R; Wang JZ
Neurobiol Aging; 2013 Mar; 34(3):745-56. PubMed ID: 22892311
[TBL] [Abstract][Full Text] [Related]
32. Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice.
Ittner A; Bertz J; Suh LS; Stevens CH; Götz J; Ittner LM
J Neurochem; 2015 Jan; 132(1):135-45. PubMed ID: 25041093
[TBL] [Abstract][Full Text] [Related]
33. A 4R tauopathy develops without amyloid deposits in aged cat brains.
Poncelet L; Ando K; Vergara C; Mansour S; Suain V; Yilmaz Z; Reygel A; Gilissen E; Brion JP; Leroy K
Neurobiol Aging; 2019 Sep; 81():200-212. PubMed ID: 31306814
[TBL] [Abstract][Full Text] [Related]
34. Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy.
Bhaskar K; Hobbs GA; Yen SH; Lee G
Neuropathol Appl Neurobiol; 2010 Oct; 36(6):462-77. PubMed ID: 20609109
[TBL] [Abstract][Full Text] [Related]
35. Possible role of tau in mediating pathological effects of apoE4 in vivo prior to and following activation of the amyloid cascade.
Inbar D; Belinson H; Rosenman H; Michaelson DM
Neurodegener Dis; 2010; 7(1-3):16-23. PubMed ID: 20160452
[TBL] [Abstract][Full Text] [Related]
36. Interneuronal transfer of human tau between Lamprey central neurons in situ.
Kim W; Lee S; Jung C; Ahmed A; Lee G; Hall GF
J Alzheimers Dis; 2010; 19(2):647-64. PubMed ID: 20110609
[TBL] [Abstract][Full Text] [Related]
37. Analysis of ribosomal protein S6 baseline phosphorylation and effect of tau pathology in the murine brain and human hippocampus.
Klingebiel M; Dinekov M; Köhler C
Brain Res; 2017 Mar; 1659():121-135. PubMed ID: 28119058
[TBL] [Abstract][Full Text] [Related]
38. c-Abl tyrosine kinase modulates tau pathology and Cdk5 phosphorylation in AD transgenic mice.
Cancino GI; Perez de Arce K; Castro PU; Toledo EM; von Bernhardi R; Alvarez AR
Neurobiol Aging; 2011 Jul; 32(7):1249-61. PubMed ID: 19700222
[TBL] [Abstract][Full Text] [Related]
39. Ubiquitin-negative mini-pick-like bodies in the dentate gyrus in p301l tauopathy.
Ferrer I; Hernández I; Puig B; Rey MJ; Ezquerra M; Tolosa E; Boada M
J Alzheimers Dis; 2003 Dec; 5(6):445-54. PubMed ID: 14757934
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation of protein Tau by GSK3β prolongs survival of bigenic Tau.P301L×GSK3β mice by delaying brainstem tauopathy.
Crespo-Biel N; Theunis C; Borghgraef P; Lechat B; Devijver H; Maurin H; Van Leuven F
Neurobiol Dis; 2014 Jul; 67():119-32. PubMed ID: 24704314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
